Deanna L. Kirkpatrick

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,200,000 shares of common stock of…

Davis Polk advised the sole book runner, in connection with the initial public offering of 41,400,000 units of Equity Distribution Acquisition Corp., including 5,400,000 units purchased…

Davis Polk advised the representative of the several underwriters in connection with the initial public offering of 16,560,000 CAPS of Executive Network Partnering Corporation, including 2…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.25 billion aggregate principal amount of its 0.450% senior notes due 2023 and (ii) $1 billion…

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 60,000,000 units of TWC Tech Holdings II Corp., including 7,500,000…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 130,000,000 units of Foley Trasimene Acquisition Corp. II for…

Davis Polk advised the representative of the several underwriters, in connection with the initial public offering of 35,000,000 units of Star Peak Energy Transition Corp. for aggregate…

Davis Polk advised the representative of the several underwriters in connection with the initial public offering of 82,800,00 units of CC Neuberger Principal Holdings II, including 10,800…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of 5,500,000 American Depositary Shares of BioNTech SE. In addition,…